Orphenadrine Extended-Release Tablets and Ranibizumab Intraocular
Determining the interaction of Orphenadrine Extended-Release Tablets and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Orphenadrine Extended-Release Tablets-Ranibizumab ophthalmic
- Orphenadrine Extended-Release Tablets-Ranitidine
- Orphenadrine Extended-Release Tablets-Ranitidine Capsule
- Orphenadrine Extended-Release Tablets-Ranitidine Hydrochloride
- Orphenadrine Extended-Release Tablets-Ranitidine Injection
- Orphenadrine Extended-Release Tablets-Ranitidine Suspension
- Ranibizumab Intraocular-Orphenadrine Injection
- Ranibizumab Intraocular-Orphenadrine w/A.C.
- Ranibizumab Intraocular-Orphenadrine, aspirin, and caffeine
- Ranibizumab Intraocular-Orphenate
- Ranibizumab Intraocular-Orphengesic
- Ranibizumab Intraocular-Orphengesic Forte